Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | LPL | P06858 | 4/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.34 |
| ▸ | F11 | P03951 | 2/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22907359 | 1.00 | IRAK4 (0.38) | IRAK4LPLLIPGF11F2 | |
| SCHEMBL29547675 | 0.83 | IRAK4 (0.40) | IRAK4LPLLIPGF11PRMT5 | |
| SCHEMBL20120904 | 0.83 | IRAK4 (0.40) | IRAK4LPLLIPGF11PRMT5 | |
| SCHEMBL27098819 | 0.78 | ROCK2 (0.39) | IRAK4PRMT5WDR77 | |
| SCHEMBL20120376 | 0.78 | IRAK4 (0.37) | IRAK4LPLLIPGF11F2 | |
| SCHEMBL22907248 | 0.77 | LPL (0.38) | IRAK4LPLLIPGPRMT5WDR77 | |
| SCHEMBL22906574 | 0.75 | ACHE (0.40) | EGFR | |
| SCHEMBL20045112 | 0.75 | LPL (0.41) | IRAK4LPLLIPGPRMT5WDR77 | |
| SCHEMBL20710303 | 0.73 | IRAK4 (0.35) | IRAK4LPLLIPGF11IDO1 | |
| SCHEMBL16597589 | 0.73 | PRMT5 (0.42) | IRAK4F11F2F10PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3999182-A1 | TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | Arvinas Operations, Inc. (US) | 2022-05-25 | — | — | EP | disclosed |